Along with cancers previously described, ATX-LPA axis and its signaling pathways have been studied in several other carcinomas such as melanoma, where LPA signaling suppresses antigen receptor signaling, cell activation, and proliferation in CD8 T cells that express LPA5, inhibiting immune response [116] and promoting tumorigenesis. Here, LPAR5 is linked to melanoma.